Using LNT-229 glioma cells, we demonstrated that stable TIGAR gene silencing (1) was associated with higher ROS levels under hypoxic conditions, (2) increased cell death in hypoxia, and (3) sensitized cells to radiation and temozolomide. This evidence concerns the gene TIGAR and central nervous system cancer.